Provided by Tiger Trade Technology Pte. Ltd.

Metagenomi Technologies, LLC

1.23
+0.03002.50%
Volume:303.20K
Turnover:375.11K
Market Cap:46.47M
PE:-0.49
High:1.26
Open:1.22
Low:1.20
Close:1.20
52wk High:3.95
52wk Low:1.13
Shares:37.78M
Float Shares:25.57M
Volume Ratio:2.43
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4900
EPS(LYR):-2.3634
ROE:-60.61%
ROA:-28.19%
PB:0.41
PE(LYR):-0.52

Loading ...

Discovering ASX Penny Stocks: Centaurus Metals Among 3 To Watch

Simply Wall St.
·
14 hours ago

MGX Resources (ASX:MGX) Shares Confront Koolan Write Downs And Cash Rich Pivot

Simply Wall St.
·
Yesterday

MGX pivots from iron ore to gold as Koolan Island wind-down funds Central Tanami push

TIPRANKS
·
Aug 21

MGX Resources Posts Deeper Loss as Revenue Slumps but Expands Tanami Stake

TIPRANKS
·
Aug 21

J.P. Morgan Keeps Their Hold Rating on Metagenomi, Inc. (MGX)

TIPRANKS
·
Aug 18

ProMIS Neurosciences Q2 Net Loss Widens

Reuters
·
Aug 14

Metagenomi Therapeutics, Inc. (NASDAQ:MGX) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Simply Wall St.
·
Aug 13

Upstream Bio Q2 Net Loss Narrows Slightly on Lower R&D Costs

Reuters
·
Aug 11

Metagenomi price target lowered to $7 from $9 at Wells Fargo

TIPRANKS
·
Aug 11

Metagenomi, Inc. (MGX) Receives a Buy from Wells Fargo

TIPRANKS
·
Aug 11

Analysts’ Top Healthcare Picks: Metagenomi, Inc. (MGX), Kymera Therapeutics (KYMR)

TIPRANKS
·
Aug 11

Metagenomi Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

DiaMedica Q2 Net Loss Widen Less than Expected

Reuters
·
Aug 11

Perspective Therapeutics Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 11

Biotech Firm Nkarta Posts Q2 Net Loss; Cash Runway into 2029

Reuters
·
Aug 11

Metagenomi Q2 EPS $(0.73) Misses $(0.57) Estimate, Sales $(257.000K) Miss $2.960M Estimate

Benzinga Earnings
·
Aug 11

Metagenomi Targets 2027 Clinical Trial Start for Hemophilia a Genome-Editing Candidate MGX-001

Reuters
·
Aug 11

Metagenomi Q2 Net Loss Widens Cash Runway Seen Through 2027

Reuters
·
Aug 11

Press Release: Metagenomi Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results

Dow Jones
·
Aug 11

Metagenomi Therapeutics Inc Expected to Post a Loss of 57 Cents a Share - Earnings Preview

Reuters
·
Aug 07